Stifel Financial’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148M Buy
9,941,165
+280
+0% +$3.01K 0.12% 184
2026
Q1
$84.1M Buy
9,940,885
+1,029
+0% +$11.3K 0.08% 255
2025
Q4
$112M Buy
9,939,856
+3,328,506
+50% +$41.2M 0.1% 202
2025
Q3
$99.2M Buy
6,611,350
+3,839
+0.1% +$55.9K 0.09% 216
2025
Q2
$93.2M Buy
6,607,511
+1,899
+0% +$33.8K 0.09% 226
2025
Q1
$159M Buy
6,605,612
+46,299
+0.7% +$1.63M 0.17% 137
2024
Q4
$245M Buy
6,559,313
+50,052
+0.8% +$2.34M 0.26% 88
2024
Q3
$325M Buy
6,509,261
+28,684
+0.4% +$1.12M 0.34% 73
2024
Q2
$225M Buy
6,480,577
+253,154
+4% +$10M 0.25% 89
2024
Q1
$341M Buy
6,227,423
+1,612
+0% +$79.8K 0.39% 63
2023
Q4
$266M Buy
6,225,811
+456,062
+8% +$14.2M 0.34% 75
2023
Q3
$150M Buy
5,769,749
+150,000
+3% +$3.12M 0.21% 106
2023
Q2
$134M Hold
5,619,749
0.18% 128
2023
Q1
$76.8M Sell
5,619,749
-11
-0% -$175 0.11% 192
2022
Q4
$78M Buy
+5,619,760
New +$79.4M 0.12% 192

Other funds holding BHVN

Stifel Financial's BHVN Position: Q2 2026 in Review

Stifel Financial increased its Biohaven (BHVN) stake by 0% in Q2 2026, buying an estimated $3.01K and bringing the position to 9,941,165 shares worth $148M. The position accounts for 0.12% of the portfolio, ranked #184.

Stifel Financial first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $341M in Q1 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Stifel Financial held 9,941,165 shares of Biohaven worth $148M as of Q2 2026.
  • Stifel Financial bought 280 Biohaven shares in Q2 2026, an estimated $3.01K.
  • Biohaven made up 0.12% of Stifel Financial's portfolio in Q2 2026, its #184 holding.
  • Stifel Financial first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Stifel Financial's Biohaven position peaked at $341M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.